Objective-To determine whether serum myoglobin, creatine kinase, and creatine kinase-MB measured at admission by rapid, compact, and easy to use automated quantitative analysers (results within 10 min) helped the early identification of acute myocardial infarction. The results were compared with the data obtained from the electrocardiograms recorded at admission. Design-A prospective study. We used the rapid analyser in a prospective trial to evaluate the potential of rapid myoglobin, CK, and CK-MB analysis in the early identification of acute myocardial infarction to see whether this approach gave useful information in addition to that already available from the presenting electrocardiogram. 
(threshold of 190 Ufl) 34%, 98%, and 68%; creatine kinase-MB (threshold of 25 Uf1) 43%, 100%, and 73%. When the electrocardiographic and myoglobin data were combined the sensitivity improved to 91%, diagnostic accuracy to 96%, with specificity of 100%. The results for the electrocardiogram and creatine kinase-MB were 80%, 90%, 100% respectively and those for the electrocardiogram with creatine kinase were 80%, 89%, 98% respectively. Conclusions-Admission myoglobin, creatine kinase, and creatine kinase-MB measurements were not as useful as the electrocardiogram for the diagnosis of acute myocardial infarction. Combining the electrocardiogram and myoglobin data substantially improved the sensitivity and predictive accuracy for the diagnosis of acute myocardial infarction.
(Br Heart J 1994;71:311-315)
Earlier biochemical identification of patients with acute myocardial infarction is desirable. These patients may benefit from early application of interventions such as thrombolysis.I Though the electrocardiogram is widely used for diagnosing acute myocardial infarction its sensitivity can be as low as 60%.2 3 Myoglobin, creatine kinase (CK), and creatine kinase-MB (CK-MB) are released early after myocardial infarction.F8 Until recently, they could only be estimated either semi-quantitatively9 or by time consuming laboratory based procedures.'011 This made such estimation unsuitable for the early diagnosis of myocardial infarction.'2 Novel rapid analysers for measuring myoglobin CK, and CK-MB are now available. These give a quantitative result within 10 minutes of blood collection. The analyser is compact and can be placed in the coronary care unit and be used by clinical staff. This has made the early biochemical identification of infarct patients feasible.
We used the rapid analyser in a prospective trial to evaluate the potential of rapid myoglobin, CK, and CK-MB analysis in the early identification of acute myocardial infarction to see whether this approach gave useful information in addition to that already available from the presenting electrocardiogram.
Patients and methods

PATIENTS
We studied 94 consecutive patients who were admitted to the coronary care unit with chest pain and suspected myocardial infarction. We excluded patients who had had recent intramuscular injections. Six taken at admission and on days 2 and 3 were also sent to the laboratory for CK-MB analysis.
MYOGLOBIN ANALYSIS
We used a Behring Turbitimer system (Behringwerke Diagnostica), which is a particle-enhanced assay based on the reaction between myoglobin present in human serum or plasma and anti-myoglobin antibodies coupled to polystyrene particles. Turbidity is measured photometrically as the maximum reaction velocity (Vmax) of precipitate formation and the time required to attain Vmax. This method permits measurement on both sides of the Heidelberger-Kendall curve. The analyser (420 mm (length) x 325 mm (width) x 200 mm (height)) and printer (420 mm x 160 mm x 100 mm respectively) are compact. We pipetted 50 ul of serum into a cuvette and added 0 5 ml of reagent. The stability of the analyser (under the supervision of the biochemists) was checked twice a week with control reagents. The analyser gives a quantitative result in about a minute from the time the serum sample is taken (range 50-650 ,g/l). 13 anterior, and one lateral), nine patients had ST depression (seven anterolateral and two inferior), four patients had T wave inversion (three anterior and one inferior), and one had left bundle branch block on the presenting electrocardiogram. Of those patients in whom myocardial infarction was excluded 27 had normal electrocardiograms, 10 had T wave inversion, four had abnormal Q waves, two had abnormal Q waves and ST depression, three had ST depression, three had atrial fibrillation, and one had bradycardia on their presenting electrocardiograms.
Fifty nine patients were not given thrombolysis. Myocardial infarction was later confirmed in 14 of these patients. Eight of these patients with myocardial infarction did not have ST elevation. In the six patients with ST elevation thrombolysis was contraindicated in five and the electrocardiogram was incorrectly interpreted in one.
Five patients in whom myocardial infarction was excluded were treated with thrombolysis because their history had suggested infarction. The presenting electrocardiogram was normal in three of these patients: the other two had anterolateral T wave inversion.
ELECTROCARDIOGRAM
Only 30 (68%) of the 44 patients with confirmed myocardial infarction had the correct diagnosis made on the presenting electrocardiogram. None of the patients in whom infarction was excluded had ST elevation. This resulted in a specificity of 100% and predictive accuracy of 85% for the presenting electrocardiogram.
MYOGLOBIN
The mean (SD) myoglobin measurement of the patients with myocardial infarction (219 (185),g/1) was significantly higher than the values for those patients in whom infarction was excluded (68 (17)), p < 0-01). With the manufacturer's recommended threshold of 90,ug/l the sensitivity for diagnosing acute myocardial infarction was 75% (33 of 44 patients), the specificity was 92% (46 of 50 patients), and the diagnostic accuracy was 84%.
However the highest myoglobin measurement for our series of patients without infarcts was 112 pug/l. We therefore also determined the diagnostic yield at a myoglobin threshold of 120,ug/l when acute myocardial infarction was correctly identified in 25 of the 44 patients. This gave a sensitivity of 57%, a specificity of 100%, and a predictive accuracy U/l) was significantly higher than in those patients in whom infarction was subsequently excluded (mean 7(5) U/1, p < 0-01). The manufacturer recommends that the CK-MB nostic must be >16 U/l and between 4-25% of the globin total CK to be diagnostic of acute myocardial ,globin infarction. When we used this threshold the atients sensitivity was 50% (22 of 44 patients), the ithout specificity was 92% (46 of 50 patients), and lectro-the diagnostic accuracy was 72%.
were In none of the patients without infarcts was ut ST the CK-MB value >25 U/l. At this threshold, :ardio-acute myocardial infarction was correctly identified in 19 of the 44 patients by the CK-MB reading at admission. Five infarct RAM patients without ST elevation in their presentiission ing electrocardiogram had a CK-MB reading lectro-of >25 U/l whereas none of the patients in ased a whom infarction was subsequently excluded ecom-did. This gave a sensitivity of 43%, a specimea-ficity of 100%, and predictive accuracy of 73%. Table 4 summarises the diagnostic yield using other CK-MB thresholds and figure 3 shows the CK-MB readings for all patients. 80%. The specificity and diagnostic accuracy were 100% and 90%. For a combination of CK (threshold 190 U/1) and electrocardiographic data the sensitivity was 80%, specificity 98%, and diagnostic accuracy 89%.
Discussion
These results can be available by the time the clinical details were obtained from the patients and the clinical examination performed. This system of analysis would aid the management of patients rather than merely establish a diagnosis of myocardial infarction after management decision had been made. In addition the availability of a quantitative result (rather than a semiquantitative result) will lead to a diagnostic threshold for myocardial infarction. Up to 40% of patients with acute myocardial infarction do not develop ST elevation on the admission electrocardiogram.23 The early identification of myocardial infarction in those patients without ST elevation may permit an increase in interventions aimed at reducing morbidity and mortality.' Though these interventions may greatly benefit the patients with myocardial infarcts they are not without adverse effects. Thrombolysis, for example, can cause cerebral and gastrointestinal haemorrhage. To avoid exposing patients without myocardial infarction to this, we also examined the value of using a higher myoglobin, CK, and CK-MB thresholds than recommended by the manufacturer (to achieve higher specificity). We investigated whether the use of higher thresholds would still provide useful information in addition to that already available from the electrocardiogram. Using these thresholds, we found that admission myoglobin, CK, and CK-MB readings gave a lower diagnostic yield than the presenting electrocardiogram. When we used a combination of myoglobin and electrocardiographic data, however, the sensitivity improved from 68% with the electrocardiogram data and 57% with the myoglobin results alone to 91% with both sets of data. The predictive accuracy improved from 85% and 80% respectively to 96%. Specificity was 100%. To a lesser extent than the myoglobin data, the combination of electrocardiographic data and CK or CK-MB readings also increased the sensitivity and diagnostic accuracy of either data set alone (CK to 80% and 89%, CK-MB to 80% and 90% respectively). With CK, however, the specificity was lower (98%). group.bmj.com on April 18, 2017 -Published by http://heart.bmj.com/ Downloaded from infarction but given thrombolysis will be exposed unnecessarily to their potential adverse effects. Thrombolytic therapy may, however, benefit the subset of patients with ST depression and myocardial infarction confirmed by early enzyme analysis. Future study will be needed to clarify this.
When myocardial infarction is complicated by bundle branch block it indicates more extensive myocardial damage.16 Early identification of acute myocardial infarction in these patients would be particularly helpful because they would benefit from thrombolysis. '4 In patients with suspected myocardial infarction who presented with a normal electrocardiogram in the ISIS-2 trial mortality was low (2 6%).'4 This mortality was not reduced by thrombolytic or aspirin therapy or both. Three of our patients with normal electrocardiogram were given thrombolytic therapy. In view of the potential adverse effect, thrombolysis should not be given to this group of patients.
The purpose of this study was to determine whether the myoglobin, CK, and CK-MB values at admission are helpful in the early identification of acute myocardial infarction. A low admission reading, however, does not exclude myocardial infarction or unstable angina and these patients must not be discharged from the hospital on the basis of these results alone. As with other investigations, early biochemical analysis should be used only as an aid to the management of the patients with suspected myocardial infarction.
Our results indicate that admission myoglobin, CK, and CK-MB have a lower sensitivity and diagnostic accuracy for the diagnosis of acute myocardial infarction than the admission electrocardiogram. However, myoglobin readings in particular provide valuable information in addition to that obtained from the presenting electrocardiogram. Combining the myoglobin and electrocardiographic data substantially increases the sensitivity and diagnostic accuracy provided by either value alone. Studies are needed to assess how this information can help the management of the coronary care unit and the administration of thrombolysis. 
